Health & Biotech
How tech is changing healthcare, and where professional ASX investors are looking
Health & Biotech
Medicinal cannabis manufacturing becomes a key focus for WA
Health & Biotech
How COVID-19 has smashed down the doors to medical cannabis
Health & Biotech
Nutritional Growth Solutions sees US sales spike during COVID-19
Health & Biotech
Prescient, Antisense the only green shoots in a sea of red
Health & Biotech
Dr Boreham’s Crucible: Dimerix not putting all its eggs in one basket
Health & Biotech
Imricor gets distribution boost in Europe with new Philips deal
Health & Biotech
Shares in new IPO Aroa Biosurgery have now doubled in a week
Health & Biotech
Osprey confirms deal with GE Healthcare to cap 300pc rally in July
Health & Biotech
CannPal closes quarter with cash and commercialisation plans
Health & Biotech
Health Kick Podcast: Botanix is using synthetic cannabinoids to treat acne and other skin conditions
Health & Biotech
COVID-19 testing will last for ‘several years not several months’
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.